Literature DB >> 29510138

AIM2 accelerates the atherosclerotic plaque progressions in ApoE-/- mice.

Jinyu Pan1, Li Han2, Jun Guo2, Xuyang Wang1, Dian Liu1, Jingjing Tian1, Mingjun Zhang1, Fengshuang An3.   

Abstract

Plaque formation is initiated and triggered by cell death in the vascular wall, which gradually leads to the progression of atherosclerosis. Pyroptosis is a newly discovered form of programmed cell death. Absent in melanoma 2 (AIM2), a member of the HIN-200 protein family, plays an important role in activating inflammasomes. However, the role and mechanism of AIM2 in atherosclerotic plaque progression has not been thoroughly elucidated to date. The effect of pyroptosis and the mechanism for this effect were investigated in apolipoprotein E-deficient (ApoE-/-) mice. AIM2 overexpression and inhibition were studied in ApoE-/- mice that were fed a high-fat diet. The specific role of AIM2 in vascular smooth muscle cells (VSMCs) was explored in vitro. The results showed that high fat diet increases the expression of AIM2, ICMA-1, GSDMD-N, which could be mediated by AIM2 expression. The plaque lesion area is lager with AIM2 overexpression. Moreover, TUNEL-positive cells were increased when AIM2 was overexpressed. With increased AIM2, macrophages were enhanced. In vitro studies showed that AIM2 and GSDMD-N expression correlated with ox-LDL levels in a concentration dependent manner. AIM2 expression is associated with NF-κB signaling activity and can be inhibited by NF-κB inhibitor. AIM2 mediated GSDMD activity through ASC, caspase1 pathway. EthD-III and TUNEL staining showed that AIM2 mediates pyroptosis in VSMCs. Our study suggests that AIM2 is not only a regular of inflammasome but also an active participant in atherosclerosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIM2; Atherosclerosis; GSDMD; NF-κB signaling; Pyroptosis; Vascular smooth muscle cells

Mesh:

Substances:

Year:  2018        PMID: 29510138     DOI: 10.1016/j.bbrc.2018.03.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

2.  Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance.

Authors:  Zhenwei Gong; Xinyi Zhang; Kai Su; Ruihua Jiang; Zhe Sun; Wei Chen; Erick Forno; Eric S Goetzman; Jieru Wang; H Henry Dong; Partha Dutta; Radhika Muzumdar
Journal:  Diabetologia       Date:  2019-09-11       Impact factor: 10.122

Review 3.  Pyroptosis-Induced Inflammation and Tissue Damage.

Authors:  Yinan Wei; Ling Yang; Ankit Pandeya; Jian Cui; Yan Zhang; Zhenyu Li
Journal:  J Mol Biol       Date:  2021-10-13       Impact factor: 5.469

Review 4.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

Review 5.  The advances in pyroptosis initiated by inflammasome in inflammatory and immune diseases.

Authors:  Faqin Liang; Feng Zhang; Lingling Zhang; Wei Wei
Journal:  Inflamm Res       Date:  2020-01-13       Impact factor: 6.986

Review 6.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 7.  Role of pyroptosis in cardiovascular disease.

Authors:  Zeng Zhaolin; Li Guohua; Wu Shiyuan; Wang Zuo
Journal:  Cell Prolif       Date:  2018-12-07       Impact factor: 6.831

8.  AIM2 Stimulation Impairs Reendothelialization and Promotes the Development of Atherosclerosis in Mice.

Authors:  Enzo Lüsebrink; Philip Roger Goody; Catharina Lahrmann; Anna Flender; Sven Thomas Niepmann; Andreas Zietzer; Christian Schulz; Steffen Massberg; Felix Jansen; Georg Nickenig; Sebastian Zimmer; Alexander Otto Krogmann
Journal:  Front Cardiovasc Med       Date:  2020-11-11

Review 9.  Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.

Authors:  Santosh V Suryavanshi; Igor Kovalchuk; Olga Kovalchuk
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

Review 10.  Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis.

Authors:  Lin Lin; Mu-Xin Zhang; Lei Zhang; Dan Zhang; Chao Li; Yun-Lun Li
Journal:  Front Cell Dev Biol       Date:  2022-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.